US Patent Issued to BIOPROJET PHARMA on March 24 for "Method for treating central nervous system disorders using dopamine D3 partial agonists" (French Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,648, issued on March 24, was assigned to BIOPROJET PHARMA (Paris).

"Method for treating central nervous system disorders using dopamine D3 partial agonists" was invented by Jeanne-Marie Lecomte (Paris), Jean Charles Schwartz (Paris), Isabelle Berrebi-Bertrand (Pace, France), Stephane Krief (Rennes, France), Xavier Ligneau (Saint-Gregoire France, France) and Isabelle Lecomte (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a method of using D3 partial agonists for treating or inhibiting the restless leg syndrome, binge eating, essential tremor and neurodegenerative diseases, in particular D3 partial agonists/D2 antagonists."

The p...